Structures by: Lynch D. E.

Total: 192

Tetra(2-amino-4,6-dimethylpyrimidinium) bis(sulfosalicylate) dihydrate

2(C6H10N3),C7H4O6S,H2O

Kasthuri BalasubramaniPackianathan Thomas MuthiahDaniel E Lynch

Chemistry Central Journal (2007) 1, 28

a=9.2466(2)Å   b=14.0976(3)Å   c=17.6365(4)Å

α=94.0280(10)°   β=101.1930(10)°   γ=91.9680(10)°

Pyrimethamine benzene sulfonate monohydrate

C72H76Cl4N16O14S4

Kasthuri BalasubramaniPackianathan Thomas MuthiahDaniel E Lynch

Chemistry Central Journal (2007) 1, 28

a=10.2783(3)Å   b=13.6919(3)Å   c=15.4164(4)Å

α=102.863(2)°   β=102.187(2)°   γ=108.805(2)°

3-Hexyl-2-(3-(3-hexyl-3H-benzoselenazol-2-ylidenemethyl)-2- methoxy-4-oxocyclobut-2-enylidenemethyl)benzoselenazol-3-ium trifluoromethanesulfonate

C33H39N2O2Se2,CF3O3S

Santos, Paulo F.Reis, Lucinda V.Almeida, PauloLynch, Daniel E.

CrystEngComm (2011) 13, 5 1333

a=9.1131(18)Å   b=25.500(5)Å   c=14.645(3)Å

α=90.00°   β=98.376(2)°   γ=90.00°

2-(2-Diethylamino-3-hexyl-2-(3-(3-hexyl-3H-benzoselenazol-2- ylidenemethyl)-4-oxocyclobut-2-enylidenemethyl)-3-hexylbenzoselenazol-3- ium trifluoromethanesulfonate

C36H46N3OSe2,CF3O3S

Santos, Paulo F.Reis, Lucinda V.Almeida, PauloLynch, Daniel E.

CrystEngComm (2011) 13, 5 1333

a=23.4215(9)Å   b=13.4127(3)Å   c=25.2899(9)Å

α=90.00°   β=112.4820(10)°   γ=90.00°

4-((3-hexylbenzoselenazol-3-ium-2-yl)methylidene)-2-((3-hexyl- 3H-benzoselenazol-2-ylidene)methyl)-3-oxocyclobut-1-en-1-olate

C32H36N2O2Se2

Santos, Paulo F.Reis, Lucinda V.Almeida, PauloLynch, Daniel E.

CrystEngComm (2011) 13, 5 1333

a=11.0233(11)Å   b=9.7399(9)Å   c=13.1575(13)Å

α=90.00°   β=98.227(5)°   γ=90.00°

3-Hexyl-2-(3-(3-hexyl-3H-benzoselenazol-2-ylidenemethyl)-2- methylamino-4-oxocyclobut-2-enylidenemethyl)benzoselenazol-3-ium trifluoromethanesulfonate hydrate

C33H40N3OSe2,CF3O3S,H2O

Santos, Paulo F.Reis, Lucinda V.Almeida, PauloLynch, Daniel E.

CrystEngComm (2011) 13, 5 1333

a=12.8136(3)Å   b=13.1269(4)Å   c=13.1817(4)Å

α=109.0220(10)°   β=98.479(2)°   γ=116.8880(10)°

2(ax)-benzoyloxy-3(ax)-(1,1,3,3-tetramethyl-2,3-dihydro-isoindol-2-ylo xy)-trans- decalin

C29H37NO3

Busfield, W. KenByriel, Karl A.Grice, I. DarrenJenkins, Ian D.Lynch, Daniel E.

Journal of the Chemical Society, Perkin Transactions 2 (2000) 4 757

a=14.904(6)Å   b=10.0510(10)Å   c=17.289(9)Å

α=90.00°   β=98.12(2)°   γ=90.00°

Morpholinium salicylate

C4H10NO,C7H5O3

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section C (2016) 72, 2 105-111

a=6.7342(10)Å   b=7.8271(10)Å   c=10.7822(17)Å

α=90.00°   β=96.442(13)°   γ=90.00°

Morpholinium 3,5-dinitrosalicylate

C4H10NO,C7H3N2O7

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section C (2016) 72, 2 105-111

a=17.8382(11)Å   b=10.3220(7)Å   c=14.5599(11)Å

α=90.00°   β=101.060(6)°   γ=90.00°

Morpholinium 3,5-dinitrobenzoate

C4H10NO,C7H3N2O6

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section C (2016) 72, 2 105-111

a=21.208(2)Å   b=5.6443(4)Å   c=23.9753(19)Å

α=90.00°   β=116.326(12)°   γ=90.00°

Morpholinium 4-nitroanthranilate

C4H10NO,C7H5N2O4

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section C (2016) 72, 2 105-111

a=9.1015(7)Å   b=7.1128(6)Å   c=19.2693(16)Å

α=90.00°   β=91.233(7)°   γ=90.00°

Tryptaminium 3,5-dinitrobenzoate--quinoline--water (3/3/2/2)

3(C10H13N2),3(C7H3N2O6),2(C9H7N),2(H2O)

Lynch, Daniel E.Smith, GrahamKeene, Tony D.Horton, Peter N.

Acta Crystallographica Section C (2016) 72, 10 738-742

a=14.5210(8)Å   b=15.5102(9)Å   c=15.6438(9)Å

α=80.506(5)°   β=88.951(5)°   γ=70.168(5)°

2-amino-2-thiazolinium indole-2-carboxylate

C3H7N2S,C9H6NO2

Lynch, Daniel E.Nicholls, Laura J.Smith, GrahamByriel, Karl A.Kennard, Colin H. L.

Acta Crystallographica Section B (1999) 55, 5 758-766

a=8.771(2)Å   b=13.344(5)Å   c=11.036(2)Å

α=90.00°   β=108.314(8)°   γ=90.00°

2-amino-2-thiazolinium N-methylpyrrole-2-carboxylate

C3H7N2S,C6H6NO2

Lynch, Daniel E.Nicholls, Laura J.Smith, GrahamByriel, Karl A.Kennard, Colin H. L.

Acta Crystallographica Section B (1999) 55, 5 758-766

a=11.9723(8)Å   b=12.5938(10)Å   c=15.063(2)Å

α=90.00°   β=90.00°   γ=90.00°

2-Aminobenzothiazolium indole-2-carboxylate

C7H7N2S,C9H6NO2

Lynch, Daniel E.Nicholls, Laura J.Smith, GrahamByriel, Karl A.Kennard, Colin H. L.

Acta Crystallographica Section B (1999) 55, 5 758-766

a=10.182(4)Å   b=11.923(2)Å   c=12.284(6)Å

α=90.00°   β=107.23(2)°   γ=90.00°

2-aminobenzothiazolium N-methylpyrrole-2-carboxylate

C7H7N2S,C6H6NO2

Lynch, Daniel E.Nicholls, Laura J.Smith, GrahamByriel, Karl A.Kennard, Colin H. L.

Acta Crystallographica Section B (1999) 55, 5 758-766

a=5.5561(9)Å   b=19.701(3)Å   c=12.143(2)Å

α=90.00°   β=100.263(8)°   γ=90.00°

2-aminobenzothiazolium thiophene-2-carboxylate

C7H7N2S,C5H3O2S

Lynch, Daniel E.Nicholls, Laura J.Smith, GrahamByriel, Karl A.Kennard, Colin H. L.

Acta Crystallographica Section B (1999) 55, 5 758-766

a=9.162(2)Å   b=11.121(3)Å   c=12.033(2)Å

α=90.00°   β=104.388(9)°   γ=90.00°

5-(4-Bromophenyl)-1,3,4-thiadiazol-2-amine--4-nitrobenzoic acid (1/1)

C8H6BrN3S,C7H5NO4

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2014) 70, 11 294-297

a=8.5205(6)Å   b=12.0394(7)Å   c=31.4321(18)Å

α=90.00°   β=92.982(6)°   γ=90.00°

2-Amino-5-(4-bromophenyl)-1,3,4-thiadiazol-3-ium 3,5-dinitrosalicylate

C8H7BrN3S,C7H3N2O7

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2014) 70, 11 294-297

a=5.8017(3)Å   b=10.1903(5)Å   c=15.1592(9)Å

α=88.884(4)°   β=82.438(5)°   γ=85.470(4)°

Morpholinium (2,4-dichlorophenoxy)acetate

C4H10NO,C8H5Cl2O3

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 11 1392-1396

a=9.3657(5)Å   b=7.1702(3)Å   c=21.1340(11)Å

α=90.00°   β=97.981(5)°   γ=90.00°

Erbium(III) 4-aminobenzoate trihydrate

C42H44Er2N6O16,2(H2O)

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 12 1457-1461

a=9.0332(5)Å   b=10.9363(6)Å   c=12.6194(6)Å

α=89.015(4)°   β=72.105(5)°   γ=74.814(5)°

Erbium 4-chloro-3-nitrobenzoate dimethyl sulfoxide

C46H30Cl6Er2N6O26S2

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 12 1457-1461

a=8.2408(3)Å   b=12.4040(8)Å   c=15.3409(10)Å

α=111.443(6)°   β=98.063(4)°   γ=96.684(4)°

Morpholinium phenoxyacetate

C4H10NO,C8H7O3

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 11 1392-1396

a=5.7079(5)Å   b=9.7735(9)Å   c=11.3586(10)Å

α=78.277(7)°   β=86.171(7)°   γ=77.512(7)°

Morpholinium (4-fluorophenoxy)acetate

C4H10NO,C8H6FO3

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 11 1392-1396

a=5.7997(5)Å   b=10.2605(10)Å   c=10.4836(11)Å

α=88.388(8)°   β=82.792(8)°   γ=80.325(8)°

Morpholinium (3,5-dichlorophenoxy)acetate

C4H10NO,C8H5Cl2O3

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 11 1392-1396

a=5.1733(4)Å   b=11.3751(10)Å   c=11.7808(10)Å

α=86.904(7)°   β=85.106(7)°   γ=77.936(7)°

1-Aza-8-azoniabicyclo[5.4.0]undec-7-ene 4-aminobenzoate

C9H17N2,C7H6NO2

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2016) 72, 3 382-386

a=8.0986(4)Å   b=12.9213(6)Å   c=13.7344(7)Å

α=90.00°   β=90.00°   γ=90.00°

Aza-8-azoniabicyclo[5.4.0]undec-7-ene 3,5-dinitrobenzoate

C9H17N2,C7H3N2O6

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2016) 72, 3 382-386

a=6.0197(4)Å   b=19.6228(13)Å   c=14.3866(8)Å

α=90.00°   β=98.078(5)°   γ=90.00°

1-Aza-8-azoniabicyclo[5.4.0]undec-7-ene 2-hydroxy-3,5-dinitrobenzoate

C9H17N2,C7H3N2O7

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2016) 72, 3 382-386

a=6.1537(3)Å   b=19.1541(14)Å   c=14.5527(11)Å

α=90.00°   β=98.343(6)°   γ=90.00°

Tryptaminium (2,4-dichlorophenoxy)acetate

C10H13N2,C8H5Cl2O3

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 6 671-674

a=8.9818(11)Å   b=6.8899(7)Å   c=14.6850(15)Å

α=90.00°   β=93.565(9)°   γ=90.00°

Tryptaminium (3,5-dichlorphenoxy)acetate

C10H13N2,C8H5Cl2O3

Smith, GrahamLynch, Daniel E.

Acta Crystallographica Section E (2015) 71, 6 671-674

a=9.5154(8)Å   b=6.1951(5)Å   c=15.3646(9)Å

α=90.00°   β=102.579(7)°   γ=90.00°

Zoxazolamine

C7H5ClN2O

Daniel E. Lynch

Acta Crystallographica Section E (2004) 60, 10 o1715-o1716

a=9.4403(19)Å   b=3.7390(7)Å   c=19.737(4)Å

α=90.00°   β=101.67(3)°   γ=90.00°

2-amino-4,6-dimethoxypyrimidine--4-aminobenzoic acid (1/1)

C6H9N3O2,C7H7NO2

Kaliyaperumal ThanigaimaniPackianathan Thomas MuthiahDaniel E. Lynch

Acta Crystallographica Section E (2006) 62, 7 o2976-o2978

a=6.6358(4)Å   b=7.5560(5)Å   c=27.4226(16)Å

α=90°   β=94.418(2)°   γ=90°

2-(2-Methylphenyl)-4,5-diphenyl-1<i>H</i>-imidazole

C22H18N2

Seethalakshmi, T.Puratchikody, A.Lynch, Daniel E.Kaliannan, P.Thamotharan, S.

Acta Crystallographica Section E (2006) 62, 7 o2803-o2804

a=10.7538(5)Å   b=19.3999(9)Å   c=8.7900(3)Å

α=90.00°   β=112.886(2)°   γ=90.00°

Α-Ammonium-α-methylpropionoate

NH41,C4H5O21

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o706-o707

a=10.6273(8)Å   b=9.0102(8)Å   c=11.3370(7)Å

α=90.00°   β=93.749(6)°   γ=90.00°

Benzocaine

C9H11NO2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o708-o709

a=8.198(2)Å   b=5.4300(10)Å   c=19.592(5)Å

α=90.00°   β=91.350(6)°   γ=90.00°

Ethyl 4-phenyl-2-(N-pyrrole)-1,3-thiazole-5-carboxylate

C16H14N2O2S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o745-o746

a=10.2375(4)Å   b=3.9460(2)Å   c=35.075(2)Å

α=90.00°   β=91.979(2)°   γ=90.00°

Trans-Bis(2-amino-5-methyl-1,3,4-thiadiazole-N)-bis(benzene-1-carboxylato-O- 3,5-dicarboxylic acid)copper(II) dihydrate

C24H20CuN6O12S2,2H2O

Daniel E. Lynch

Acta Crystallographica Section E (2002) 58, 10 m577-m579

a=8.4671(4)Å   b=8.7971(5)Å   c=11.6748(6)Å

α=112.096(4)°   β=90.354(3)°   γ=110.549(2)°

2-Amino-6-nitrobenzo-1,3-thiazole hydrate

C7H5N3O2S,H2O

Lynch, Daniel E.

Acta Crystallographica Section E (2002) 58, 10 o1139-o1141

a=3.8930(2)Å   b=10.8743(5)Å   c=20.6378(8)Å

α=90.00°   β=91.335(4)°   γ=90.00°

3-(4-(Methylsulfonyl)benzoyl)propionic acid

C11H12O5S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o729-o730

a=5.18510(10)Å   b=10.5030(3)Å   c=10.9550(4)Å

α=96.9900(10)°   β=101.1350(10)°   γ=101.786(3)°

5-(4-Fluorophenyl)-1-phenylpyrazole

C15H11FN2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o731-o732

a=7.847(2)Å   b=7.904(2)Å   c=19.551(4)Å

α=90.20(3)°   β=100.92(3)°   γ=90.61(3)°

Ethyl 4-tert-butyl-2-(3-phenylureido)-1,3-thiazole-5-carboxylate

C17H21N3O3S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o733-o734

a=6.1391(4)Å   b=9.9755(6)Å   c=28.248(2)Å

α=90.00°   β=90.00°   γ=90.00°

2-(N,N-Dimethylaminomethyl)-4-hydroxy-4-phenyl-2-thiazoline

C12H15ClN2OS

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o710-o711

a=6.1186(8)Å   b=9.3865(9)Å   c=11.977(2)Å

α=103.473(4)°   β=97.274(5)°   γ=93.320(10)°

Diethyl (4-tert-butyl-1,3-thiazol-2-ylaminomethylene)malonate

C15H23N2O4S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 2 o242-o243

a=19.663(4)Å   b=13.177(3)Å   c=13.708(3)Å

α=90.00°   β=103.69(3)°   γ=90.00°

2-Amino-4-(4-chlorophenylthio)-5-phenyl-6-(1-piperidyl)pyrimidine

C21H21ClN4S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 2 o222-o224

a=14.645(3)Å   b=6.4302(13)Å   c=20.954(4)Å

α=90.00°   β=98.67(3)°   γ=90.00°

2-(4-Methoxyphenyl)-5-(4-methylpent-3-enyl)-2,3,3a,4,7,7a-hexahydro- 1H-isoindole-1,3-dione

C21H25NO3

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 2 o198-o199

a=17.001(2)Å   b=6.5492(10)Å   c=17.145(3)Å

α=90.00°   β=110.584(5)°   γ=90.00°

10-Methoxydibenz[b,f]azepine-5-carboxamide

C16H14N2O2

Basavegowda NagarajHemmige S. YathirajanRajenahally S. NarasegowdaPadmarajaiah NagarajaDaniel E. Lynch

Acta Crystallographica Section E (2005) 61, 6 o1760-o1761

a=8.8003(2)Å   b=9.2012(2)Å   c=9.3735(3)Å

α=64.6999(16)°   β=76.0520(15)°   γ=83.7398(18)°

2-Chloro-3-(3-dimethylaminopropylamino)-1,4-naphthoquinone

C15H17ClN2O2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 9 o1427-o1428

a=8.0693(8)Å   b=13.0020(10)Å   c=13.931(2)Å

α=90.00°   β=105.623(4)°   γ=90.00°

Tris(2-ammonioethyl)amine benzene-1,3,5-tricarboxylate 5.5-hydrate

C6H21N43,C9H3O63,5.5H2O

Daniel E. Lynch

Acta Crystallographica Section E (2003) 59, 7 o1076-o1078

a=9.5850(10)Å   b=10.7110(10)Å   c=12.980(2)Å

α=72.790(10)°   β=73.670(10)°   γ=62.93(8)°

4-Chloro-2-methylthio-6-(piperidin-1-yl)pyrimidine

C10H14ClN3S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o200-o201

a=13.189(3)Å   b=8.577(2)Å   c=20.195(4)Å

α=90.00°   β=90.00°   γ=90.00°

4,6-Dichloro-2-methylthio-5-phenylpyrimidine

C11H8Cl2N2S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o264-o265

a=7.467(2)Å   b=16.217(3)Å   c=19.318(4)Å

α=90.00°   β=90.00°   γ=90.00°

6-Chloro-2-methylthio-4-[(2-phenylethyl)amino]pyrimidine

C26H28Cl2N6S2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o198-o199

a=20.038(4)Å   b=11.358(2)Å   c=12.043(2)Å

α=90.00°   β=92.03(3)°   γ=90.00°

1-(3-Chloro-4-methylphenyl)pyrroline-2,5-dione

C11H8ClNO2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 2 o147-o148

a=10.473(2)Å   b=24.303(5)Å   c=3.8594(8)Å

α=90.00°   β=90.00°   γ=90.00°

2-Chloro-3-(4-methylpiperizino)-1,4-naphthoquinone

C15H15ClN2O2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o287-o288

a=12.379(3)Å   b=9.389(2)Å   c=12.995(3)Å

α=90.00°   β=116.60(3)°   γ=90.00°

N-(4-Acetylphenyl)maleamic acid

C12H11NO4

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 6 o678-o679

a=5.5577(3)Å   b=25.5016(14)Å   c=7.4588(5)Å

α=90.00°   β=95.134(2)°   γ=90.00°

3-Cyano-6-(4-methoxyphenyl)-2(1H)-pyridone

C13H10N2O2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 6 o680-o681

a=10.6650(7)Å   b=9.8140(8)Å   c=11.1544(12)Å

α=90.00°   β=108.833(3)°   γ=90.00°

4-Methyl-2-(8-quinolyl)phthalazin-1-one

C18H13N3O

Lynch, Daniel E.Ian McClenaghan

Acta Crystallographica Section E (2002) 58, 10 o1051-o1052

a=7.9530(4)Å   b=8.4914(6)Å   c=10.8850(7)Å

α=77.060(6)°   β=74.114(5)°   γ=86.277(3)°

2-phenylpyrrolo[2,3-h]quinoline dihydrate

C17H12N2,2H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 10 o1150-o1151

a=24.758(4)Å   b=24.758(4)Å   c=4.6952(9)Å

α=90.00°   β=90.00°   γ=90.00°

8-Hydrazinoquinoline dihydrochloride hydrate

C9H11N3,H2O,2Cl

Daniel E. Lynch

Acta Crystallographica Section E (2002) 58, 10 o1070-o1071

a=6.9716(14)Å   b=8.9866(18)Å   c=9.986(2)Å

α=70.04(3)°   β=89.20(3)°   γ=69.60(3)°

2,4-Bis(3,3-dimethyl-1-octylindolin-2-ylidenemethyl)cyclobutenediylio-1,3- diolate

C42H56N2O2

Lynch, Daniel E.

Acta Crystallographica Section E (2002) 58, 9 o1025-o1027

a=9.2547(4)Å   b=16.2169(8)Å   c=12.2437(7)Å

α=90.00°   β=103.569(2)°   γ=90.00°

Bisquinolinium tetrachlorocopper(II) dihydrate

2C9H8N1,Cl4Cu2,2H2O

Daniel E. LynchIan MClenaghan

Acta Crystallographica Section E (2002) 58, 10 m551-m553

a=11.815(2)Å   b=9.837(2)Å   c=18.311(4)Å

α=90.00°   β=101.05(3)°   γ=90.00°

Hydrindantin

C18H10O6,2H2O

Daniel E. Lynch

Acta Crystallographica Section E (2003) 59, 8 o1133-o1134

a=8.4479(4)Å   b=12.4759(6)Å   c=7.9293(4)Å

α=90.00°   β=100.634(3)°   γ=90.00°

Ethane-1,2-diammonium bis(4-nitrobenzoate) bishydrate

C2H10N22,2C7H4NO41,2H2O

Daniel E. LynchPeter C. Healy

Acta Crystallographica Section E (2003) 59, 7 o1058-o1059

a=12.213(2)Å   b=22.317(2)Å   c=7.091(5)Å

α=89.47(2)°   β=89.17(2)°   γ=84.72(8)°

Tris(2-ethylammonio)amine--4-nitrobenzoate--water (2/6/4)

C6H21N43,3C7H4NO41,2H2O

Daniel E. Lynch

Acta Crystallographica Section E (2003) 59, 8 o1157-o1158

a=14.0950(10)Å   b=14.6970(10)Å   c=17.1308(7)Å

α=103.758(5)°   β=99.715(6)°   γ=105.898(7)°

Tris(2-ammonioethyl)amine tris({2-[(2,6-dichlorophenyl)amino]phenyl}acetate) hexahydrate

C6H21N43,3C14H10Cl2NO21,6H2O

Daniel E. LynchAjmer S. BeningSimon Parsons

Acta Crystallographica Section E (2003) 59, 9 o1314-o1317

a=22.677(4)Å   b=9.3735(17)Å   c=26.415(5)Å

α=90.00°   β=105.176(17)°   γ=90.00°

2-(Benzoylmethylsulfanyl)-6-methoxy-1H-benzimidazole

C16H14N2O2S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2004) 60, 3 o363-o364

a=5.7681(3)Å   b=9.8914(6)Å   c=24.4281(16)Å

α=90.00°   β=96.798(3)°   γ=90.00°

Methylene blue nitrate dihydrate

C16H18N3S,NO3,2H2O

Savaridasson Jose KavithaMani Mohan RajKrishnaswamy PanchanatheswaranDaniel E. Lynch

Acta Crystallographica, Section E (2004) 60, 8 o1366-o1368

a=7.6985(3)Å   b=10.9638(3)Å   c=11.3244(4)Å

α=87.081(2)°   β=76.032(2)°   γ=73.524(2)°

6,6,8a-Trimethyl-3a,6,7,8a-tetrahydrobenzo[b]furo[3,2-d]furan-2,4(3H,5H)-dione

C13H16O4

Basavegowda NagarajHemmige S. YathirajanPadmarajaiah NagarajaDaniel E. Lynch

Acta Crystallographica Section E (2005) 61, 4 o1041-o1042

a=9.4853(3)Å   b=10.2904(2)Å   c=12.2872(4)Å

α=90.00°   β=90.00°   γ=90.00°

10-Methoxy-5H-dibenz[b,f]azepine

C15H13NO

Basavegowda NagarajHemmige S. YathirajanDaniel E. Lynch

Acta Crystallographica Section E (2005) 61, 6 o1757-o1759

a=54.925(11)Å   b=5.8189(12)Å   c=21.628(4)Å

α=90.00°   β=98.14(3)°   γ=90.00°

1-(10,11-Dihydrodibenz[b,f]azepin-5-yl)ethanone

C16H15NO

Basavegowda NagarajHemmige S. YathirajanDaniel E. Lynch

Acta Crystallographica Section E (2005) 61, 6 o1609-o1610

a=9.5674(2)Å   b=11.7020(3)Å   c=22.2785(4)Å

α=90.00°   β=90.00°   γ=90.00°

Trimethoprim fluoroborate

C14H19N4O3,BF4

Madhukar HemamaliniPackianathan Thomas MuthiahDaniel E. Lynch

Acta Crystallographica Section E (2005) 61, 12 o4107-o4109

a=9.4105(3)Å   b=9.5397(2)Å   c=10.1276(4)Å

α=88.564(2)°   β=73.253(2)°   γ=72.304(2)°

1-Isopropyl-6,6,8a-trimethyl-1,3a,5,6,7,8a-hexahydro-3H- 1-benzofuro[2,3-b]pyrrole-2,4-dione

C16H23NO3

Narasegowda, R. N.Yathirajan, H. S.Lynch, D. E.Narasimhamurthy, T.Rathore, R. S.

Acta Crystallographica Section E (2006) 62, 4 o1328-o1329

a=8.9725(3)Å   b=10.2472(3)Å   c=10.4372(3)Å

α=101.733(2)°   β=109.2900(10)°   γ=115.7650(10)°

Kynathrin 4-hydroxy benzoic acid

C6H9N3,C7H6O3

Kasthuri BalasubramaniPackianathan Thomas MuthiahDaniel E. Lynch

Acta Crystallographica Section E (2006) 62, 7 o2907-o2909

a=9.0693(3)Å   b=11.1141(4)Å   c=12.6080(5)Å

α=90°   β=102.916(2)°   γ=90°

2-Chloro-3-[4-(ethoxycarbonyl)-1-piperidyl]-1,4-naphthoquinone

C18H18ClNO4

Lynch, Daniel E.McClenaghan, IanColes, Simon J.

Acta Crystallographica Section E (2001) 57, 2 o125-o126

a=12.780(3)Å   b=16.931(3)Å   c=7.8532(16)Å

α=90.00°   β=101.85(3)°   γ=90.00°

5-tert-butyl-4-nitro-1H-pyrazol-3-ol

C7H11N3O3

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 8 o2347-o2348

a=6.4870(5)Å   b=6.6560(4)Å   c=11.5588(8)Å

α=81.227(4)°   β=76.733(3)°   γ=65.037(5)°

5-tert-Butyl-4-bromo-1,2-dihydro-1H-pyrazol-3(2H)-one monohydrate

C7H11BrN2O,H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 8 o2349-o2351

a=13.6840(4)Å   b=13.6840(4)Å   c=21.4734(8)Å

α=90.00°   β=90.00°   γ=90.00°

4-Hydroxy-6-methyl-2-(sulfonatoethylsulfanyl)pyrimidin-1-ium monohydrate

C7H10N2O4S2,H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2004) 60, 3 o376-o377

a=6.1137(2)Å   b=11.2202(3)Å   c=15.9632(6)Å

α=90.00°   β=91.0483(18)°   γ=90.00°

N,N'-di-n-tetradecylpyromellitic diimide

C38H60N2O4

Daniel E. LynchDarren G. Hamilton

Acta Crystallographica Section E (2004) 60, 4 o597-o598

a=38.939(3)Å   b=4.9902(3)Å   c=8.9040(5)Å

α=90.00°   β=95.896(2)°   γ=90.00°

8-(2-Phenylethylamino)quinoline

C17H16N2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o4-o5

a=10.1202(3)Å   b=9.9645(3)Å   c=13.8592(5)Å

α=90.00°   β=110.7743(11)°   γ=90.00°

4-Amino-6-imidium-1,3,5-dithiazol-4-ene iodide

C3H6N3S21,I1

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o70-o71

a=11.050(2)Å   b=18.964(4)Å   c=8.1307(16)Å

α=90.00°   β=108.87(3)°   γ=90.00°

11H-Pyridinium[2,3h]-7,8,9,10-tetrahydrocarbazole chloride

C15H15N21,Cl1

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o43-o44

a=15.9111(6)Å   b=5.0374(2)Å   c=17.1233(9)Å

α=90.00°   β=113.9330(17)°   γ=90.00°

4-Methoxy-3-nitropyridinium chloride

C6H7N2O31,Cl1

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o83-o84

a=10.6185(4)Å   b=7.1517(4)Å   c=11.3701(5)Å

α=90.00°   β=111.523(3)°   γ=90.00°

8-(Isoindol-1,3-dione-2-yl)aminoquinoline

C17H11N3O2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o16-o17

a=16.397(3)Å   b=10.819(2)Å   c=7.6737(15)Å

α=90.00°   β=90.00°   γ=90.00°

2-Amino-4,6-bis(4-chlorophenylthio)pyrimidine

C32H22Cl4N6S4

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o11-o12

a=28.4777(13)Å   b=8.6020(3)Å   c=14.2055(5)Å

α=90.00°   β=102.5620(13)°   γ=90.00°

2-Amino-5-(4-methoxybenzyl)-4-methyl-1,3-thiazolium chloride

C12H15ClN2OS

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o24-o25

a=7.5746(15)Å   b=11.878(2)Å   c=14.519(3)Å

α=90.00°   β=100.47(3)°   γ=90.00°

2-Amino-4,6-bis(phenylthio)pyrimidine

C16H13N3S2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o26-o27

a=8.7937(18)Å   b=8.3091(17)Å   c=21.148(4)Å

α=90.00°   β=95.73(3)°   γ=90.00°

2-Amino-4-chloro-6-(4-carbamoylpyperidinyl)pyrimidine hemihydrate

C10H15ClN5O,0.5H2O

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o50-o51

a=15.559(3)Å   b=9.3139(19)Å   c=16.493(3)Å

α=90.00°   β=102.08(3)°   γ=90.00°

(E)-1-(2-Thienyl)ethanone 8-quinolylhydrozone

C15H13N3S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o52-o53

a=10.148(2)Å   b=14.251(3)Å   c=18.103(4)Å

α=90.00°   β=90.00°   γ=90.00°

2-Chloro-4-methylquinoline

C10H8ClN

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o54-o55

a=12.721(3)Å   b=7.8961(16)Å   c=16.617(3)Å

α=90.00°   β=90.00°   γ=90.00°

2-(4-Pyridyl)pyrrolo[3,2-h]quinoline

C32H22N6

Lynch, Daniel E.McClenaghan, IanLight, Mark E.

Acta Crystallographica Section E (2001) 57, 1 o56-o57

a=19.3539(8)Å   b=6.8609(3)Å   c=19.3579(8)Å

α=90.00°   β=112.325(2)°   γ=90.00°

Thiazolidine-2,4-dione

C3H3NO2S

Lynch, Daniel E.McClenaghan, IanLight, Mark E.

Acta Crystallographica Section E (2001) 57, 1 o79-o80

a=7.2926(2)Å   b=9.3642(3)Å   c=13.1208(5)Å

α=90.00°   β=90.00°   γ=90.00°

2-(2,4-Dichlorophenoxy)-N-(4,6-dimethylpyridin-2-yl)acetamide

C15H14Cl2N2O2

Daniel E. LynchSanjeev BaggaSimon Parsons

Acta Crystallographica Section E (2003) 59, 9 o1299-o1300

a=7.445(5)Å   b=8.790(6)Å   c=12.549(7)Å

α=89.28(4)°   β=87.08(5)°   γ=68.74(4)°

2-tert-Butyl-4,6-dinitrophenol

C10H12N2O5

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2004) 60, 8 o1288-o1289

a=9.974(2)Å   b=10.575(2)Å   c=11.547(2)Å

α=90.00°   β=112.90(3)°   γ=90.00°

2,2'-dinitrodibenzyl

C14H12N2O4

Hemmige S. YathirajanBasavegowda NagarajPadmarajaiah NagarajaDaniel E. Lynch

Acta Crystallographica Section E (2004) 60, 12 o2455-o2456

a=7.5678(8)Å   b=14.4964(16)Å   c=5.9874(5)Å

α=90.00°   β=108.607(6)°   γ=90.00°

2-Butyl-4-chloro-1-(4-nitrobenzyl)-1H-imidazole-5-carboxaldehyde

C15H16ClN3O3

Gaonkar, Santhosh L.Yathirajan, Hemmige S.Nagaraj, BasavegowdaNarasegowda, Rajenahally S.Lynch, Daniel E.

Acta Crystallographica Section E (2004) 60, 12 o2520-o2521

a=8.3007(5)Å   b=12.2295(6)Å   c=16.5605(10)Å

α=103.420(4)°   β=95.561(3)°   γ=106.758(3)°

Ethyl 2-(2-chloro-1,4-dihydro-1,4-dioxonaphthalen-3-ylamino)-4-phenylthiazole-5- carboxylate

C22H15ClN2O4S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 3 o790-o791

a=19.191(5)Å   b=7.719(2)Å   c=12.640(3)Å

α=90.00°   β=94.845(18)°   γ=90.00°

4-(2-Chloroethyl)morpholinium chloride

C6H13ClNO,Cl

Rajenahally S. NarasegowdaHemmige S. YathirajanPadmarajaiah NagarajaDaniel E. Lynch

Acta Crystallographica Section E (2005) 61, 4 o849-o850

a=6.9876(3)Å   b=8.1549(4)Å   c=8.6495(3)Å

α=63.530(2)°   β=85.004(3)°   γ=85.179(2)°

1-(Carbamoylmethyl)cyclohexanecarboxylic acid

C9H15NO3

Basavegowda NagarajHemmige S. YathirajanPadmarajaiah NagarajaDaniel E. Lynch

Acta Crystallographica Section E (2005) 61, 4 o884-o885

a=13.4973(5)Å   b=8.0905(2)Å   c=8.8358(3)Å

α=90.00°   β=102.627(2)°   γ=90.00°

Diethyl 2-aminothiazole-4,5-dicarboxylate hemihydrate

C9H12N2O4S,0.5H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 4 o824-o826

a=16.7835(4)Å   b=8.4580(2)Å   c=18.0373(5)Å

α=90.00°   β=111.6530(10)°   γ=90.00°

Na,C4H5O6,H2O1

Na,C4H5O6,H2O1

Bott, R. C.Sagatys, D. S.Lynch, D. E.Smith, G.Kennard, C. H. L.

Acta Crystallographica Section C (1993) 49, 6 1150-1152

a=7.2425(6)Å   b=8.6760(10)Å   c=10.5920(10)Å

α=90.°   β=90.°   γ=90.°

C18H15O1P1,C8H3Cl5O3

C18H15O1P1,C8H3Cl5O3

Lynch, D. E.Smith, G.Byriel, K. A.Kennard, C. H. L.

Acta Crystallographica Section C (1993) 49, 2 285-288

a=10.185(6)Å   b=12.036(5)Å   c=12.194(6)Å

α=92.21(3)°   β=108.48(3)°   γ=106.10(3)°